PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1991 | 1 |
| 1992 | 1 |
| 1995 | 1 |
| 1999 | 1 |
| 2000 | 1 |
| 2002 | 2 |
| 2004 | 2 |
| 2005 | 6 |
| 2006 | 19 |
| 2007 | 50 |
| 2008 | 70 |
| 2009 | 84 |
| 2010 | 87 |
| 2011 | 99 |
| 2012 | 76 |
| 2013 | 53 |
| 2014 | 89 |
| 2015 | 89 |
| 2016 | 66 |
| 2017 | 69 |
| 2018 | 95 |
| 2019 | 67 |
| 2020 | 58 |
| 2021 | 73 |
| 2022 | 84 |
| 2023 | 78 |
| 2024 | 70 |
| 2025 | 66 |
| 2026 | 61 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Bioconjug Chem"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Cysteine/GSH-Responsive Lipid Switch Development for Liposome Triggered Cargo Release.
- Ullah M, Shahriar KR, Mustafa MB, Best MD.
- Bioconjug Chem. Author manuscript. 2026 Oct 21;37(10):2035-2042. doi: 10.1021/acs.bioconjchem.6c00392.
- PMCID: PMC13693486
Ullah M, et al.Bioconjug Chem. Author manuscript. 2026.PMCID: PMC13693486 -
A Synergistic Approach Using a ROS-Responsive Lipid-Based Prodrug for Liposomal Delivery of Doxorubicin.
- Smith BE, Lou J, Phillips MA, Sagar R, Qualls M, McBee DP, Turner RF, Ullah M, Baccile JA, Best MD.
- Bioconjug Chem. Author manuscript. 2026 Oct 21;37(10):1975-1986. doi: 10.1021/acs.bioconjchem.6c00165.
- PMCID: PMC13693509
Smith BE, et al.Bioconjug Chem. Author manuscript. 2026.PMCID: PMC13693509 -
Mitochondria-Targeting Antimicrobial Peptide (AMP) Regulating N6-Methyladenosine (m6A) Modification to Promote Colon Cancer Ferroptosis.
- Li C, Li S, Lv L, Chen Y, Yang S, Lu Y, Dong D.
- Bioconjug Chem. 2025 Oct 13;36(11):2497-2506. doi: 10.1021/acs.bioconjchem.5c00459.
- PMCID: PMC12637310
Li C, et al.Bioconjug Chem. 2025.PMCID: PMC12637310 -
Indocyanine Green-Labeled Antibody-NOTCH2 as a New Fluorescent Molecular Imaging Probe for Gastric Cancer.
- Li M, Wang J, Li Q, Zhang X, Yang L, Li Y, He W, Liu T.
- Bioconjug Chem. 2025 Oct 8;36(11):2507-2514. doi: 10.1021/acs.bioconjchem.5c00465.
- PMCID: PMC12637303
Li M, et al.Bioconjug Chem. 2025.PMCID: PMC12637303 -
Revolutionizing Solid Tumor Surgery with Fibroblast Activation Protein (FAP)-Targeted Imaging Probes for a Fluorescence-Guided Surgery of Pancreatic Cancer.
- Ma H, de Muynck LDAN, Houvast RD, Beekman S, Piet A, March TL, Hawinkels LJAC, Mieog JSD, Vahrmeijer AL, Seimbille Y.
- Bioconjug Chem. 2025 Oct 1;36(10):2145-2157. doi: 10.1021/acs.bioconjchem.5c00218.
- PMCID: PMC12533559
Ma H, et al.Bioconjug Chem. 2025.PMCID: PMC12533559 -
Modification of Cysteine-Substituted Antibodies Using Enzymatic Oxidative Coupling Reactions.
- Cao W, Maza JC, Chernyak N, Flygare JA, Krska SW, Toste FD, Francis MB.
- Bioconjug Chem. Author manuscript. 2023 Feb 14;34(3):510-517. doi: 10.1021/acs.bioconjchem.2c00576.
- PMCID: PMC13599061
Cao W, et al.Bioconjug Chem. Author manuscript. 2023.PMCID: PMC13599061 -
"Imaging Triplets on Two Wheels": 61Cu-, 64Cu-, and 68Ga-labeled Bicyclic Peptides Targeting Nectin-4 Enable High-Contrast PET Imaging of Urothelial Carcinoma and Triple-Negative Breast Cancer.
- Mauersberger J, Krönke T, Ullrich M, Laube M, Brandt F, Pretze M, Lohaus F, Hoberück S, Thomas C, Miederer M, Bundschuh RA, Stadlbauer S, Kopka K, Pietzsch J, Wodtke R.
- Bioconjug Chem. 2026 Sep 16;37(9):1887-1904. doi: 10.1021/acs.bioconjchem.6c00366.
- PMCID: PMC13587596
Mauersberger J, et al.Bioconjug Chem. 2026.PMCID: PMC13587596 -
Identification of a Mirror-Image VHH Antibody with VEGF-Inhibitory Activity and Characterization of Its Immunogenicity.
- Maeda K, Yonemura M, Aoki K, Imahori S, Iwamoto N, Oka S, Morise J, Higashi K, Oishi S, Nonaka M.
- Bioconjug Chem. 2026 Sep 16;37(9):1845-1856. doi: 10.1021/acs.bioconjchem.6c00264.
- PMCID: PMC13588172
Maeda K, et al.Bioconjug Chem. 2026.PMCID: PMC13588172 -
Development of a Homogeneous Trastuzumab-Triptolide Conjugate for Targeted Therapy of HER2-Overexpressing Ovarian Cancer.
- Fadayomi IE, Jangan M, Varghese D, Pires E, McCullagh J, Richardson A, Brunt AM, Li WW.
- Bioconjug Chem. 2026 Sep 16;37(9):1824-1832. doi: 10.1021/acs.bioconjchem.6c00171.
- PMCID: PMC13587595
Fadayomi IE, et al.Bioconjug Chem. 2026.PMCID: PMC13587595 -
Tumor-Responsive Delivery of 5-Fluorouracil from a Redox-Triggered Supramolecular Gelator.
- Mihajlovic M, Mihajlovic M, Alletto P, Kralj S, Rosso N, Marchesan S.
- Bioconjug Chem. 2026 Aug 19;37(8):1571-1581. doi: 10.1021/acs.bioconjchem.6c00108.
- PMCID: PMC13495549
Mihajlovic M, et al.Bioconjug Chem. 2026.PMCID: PMC13495549